Endothelial Cell Senescence in Marfan Syndrome: Pathogenesis and Therapeutic Potential of TGF‐β Pathway Inhibition
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.037826 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Yuhao Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Institute of Hypoxia Medicine, School of Basic Medical Sciences Wenzhou Medical University Zhejiang China. Hauptthemen laut MEDLINE: Marfan Syndrome, Cellular Senescence, Endothelial Cells, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Marfan syndrome (MFS) is a heritable connective tissue disorder caused by mutations in the Fibrillin‐1 gene, which encodes the extracellular matrix protein fibrillin‐1. Patients with MFS are predisposed to aortic aneurysms and dissections, significantly contributing to mortality. Emerging evidence suggests that endothelial cell (EC) senescence plays a critical role in the pathogenesis of aortic aneurysms in MFS. This study aims to elucidate the role of EC senescence in the development of aortic aneurysms in MFS using a vascular model derived from human induced pluripotent stem cells. Methods and Results We generated human induced pluripotent stem cells lines from 2 patients with MFS carrying specific Fibrillin‐1 mutations and differentiated these into ECs. These MFS–hiPSC‐derived ECs were characterized using immunofluorescence, reverse transcription‐quantitative polymerase chain reaction, and Western blotting. Functional assays including cell proliferation, scratch wound, tube formation, NO content detection, and senescence‐associated β‐galactosidase staining were conducted. RNA sequencing was performed to elucidate underlying signaling pathways, and pharmacological inhibition of the transforming growth factor‐beta pathway was assessed for its therapeutic potential. MFS–hiPSC‐derived ECs recapitulated the pathological features observed in Marfan aortas, particularly pronounced cellular senescence, decreased cell proliferation, and abnormal transforming growth factor‐beta and NF‐κB signaling. These senescent ECs exhibited diminished proliferative and migratory capacities, reduced NO signaling, increased production of inflammatory cytokines, and attenuated responses to inflammatory stimuli. Importantly, senescence and dysfunction in MFS‐hiPSCderived ECs were ameliorated by transforming growth factor‐beta signaling pathway inhibitor, SB‐431542, suggesting a potential therapeutic strategy.
Conclusions
This study highlights the pivotal role of endothelial cell senescence in the pathogenesis of aortic aneurysms in MFS. Our human induced pluripotent stem cells–based disease model provides new insights into the disease mechanisms and underscores the potential of targeting the transforming growth factor‐beta pathway to mitigate endothelial dysfunction and senescence, offering a promising therapeutic avenue for MFS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Institute of Hypoxia Medicine, School of Basic Medical Sciences Wenzhou Medical University Zhejiang China.
- Department of Gerontology Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China.
- Department of Cardiac Surgery The First Affiliated Hospital of Wenzhou Medical University Zhejiang China.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences Wenzhou Medical University Zhejiang China.
- Cardiac Regeneration Research Institute, School of Basic Medical Sciences Wenzhou Medical University Zhejiang China.
ORCID-Profile: Yuhao Chen, Yuankang Zhu, Lu Ding, Miqi Zhou, Ming Li, Yongyu Wang
Zitieren
APA
Chen, Y., Zhu, Y., Ren, X., Ding, L., Xu, Y., Zhou, M., Dong, R., Jin, P., Chen, X., Fan, X., Li, M., Gong, Y., & Wang, Y. (2025). Endothelial Cell Senescence in Marfan Syndrome: Pathogenesis and Therapeutic Potential of TGF‐β Pathway Inhibition. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.037826
Vancouver
Chen Y, Zhu Y, Ren X, Ding L, Xu Y, Zhou M, et al. Endothelial Cell Senescence in Marfan Syndrome: Pathogenesis and Therapeutic Potential of TGF‐β Pathway Inhibition. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.037826
BibTeX
@article{Chen2025,
author = {Chen, Yuhao and Zhu, Yuankang and Ren, Xiaoli and Ding, Lu and Xu, Yubin and Zhou, Miqi and Dong, Runze and Jin, Peifeng and Chen, Xiufang and Fan, Xiaofang and Li, Ming and Gong, Yongsheng and Wang, Yongyu},
title = {Endothelial Cell Senescence in Marfan Syndrome: Pathogenesis and Therapeutic Potential of TGF‐β Pathway Inhibition},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.037826}
}
EUVIMED